MELONEX Profile



Product

product image
MELONEX
Company
Intas Pharmaceuticals Ltd
Group
Allopathic
Subgroup
NSAIDs
Main Combination
Melaxicam
Storage
Room Temparature
Type
Injection  
Packing
Packing
Mrp
Tax
30 ml   
Rs 0   
+ inc.tax   
15 ml   
Rs 0   
+ inc.tax   
Indication
Mode of Action:

Meloxicam is non - steroidal anti - inflammatory drug (NSAID) of the oxicam class which inhibits the synthesis of prostaglandin PGE2 by more selectively inhibiting the inducible cyclo - oxygenase (Cox 2) enzyme, thereby exerting anit - inflammatory, anti - exudative, analgesic and anti - pyretic effects.  Meloxicam has also shown to inhibit production of thromboxane B2 induced by intravenous E-coli endotoxin administration in calves.

Indications:

Pneumonia
Broncho - pneumonia
Pleuritis
Laminitis
Myositis
Sprain
Arthritis ( rheumatoid origin also)
Mastitis
Prolapse of uterus
Otitis
Premature labour
Composition
Each ml contains Melaxicam BP 5 mg
Dosage
Canine:
0.2 - 0.3 mg / kg B. Wt.
Sheep
0.2 - 0.5 mg / kg B. Wt.
Poultry
N/A
Large Animals
Single Administration of 0.5 mg / kg bwt for pneumonia or prolapse of uterus ( 30 ml for 300 kg bwt); in other indications 0.2 - 0.3 mg / kg bwt ( 15 ml for 375 kg bwt), ot be repeated daily or as directed by Veterinarian.
Others
N/A
Administration
Intramuscual, Intravenous or Subcutaneous
Advantages
No effect on the blood pressure, heart rate and respiratory volume.
No influence on water, electrolyte o r creatinine excretion.
No changes in hematological parameters.
No antagonistic properties against histamine, PGE2 and angiotensin.
Mildest gastric irritation.
Precautions
Protect from light
Go Back